ArticleScientific reports2026
Classification of rice plant diseases using efficient DenseNet121.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Microscopic image enhancement for accurate sickle cell disease identification using intuitionistic fuzzy driven retinex.Scientific reports · 2026Article
- Wavelet-prior-guided mamba network for accurate and efficient rice disease recognition.Frontiers in plant science · 2026Article
- Genetic enhancement of root, tuber and cereal crops via pangenomics, multi-omics integration and AI-driven prediction.Frontiers in plant science · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Agriculture and global food security are critically dependent on accurate and timely identification of plant diseases and pests. Traditional approaches to disease identification rely heavily on visual inspection and expert knowledge, which frequently lack the accuracy, speed, and scalability needed to address growing agricultural challenges. Early and precise disease detection enables proactive interventions that can prevent widespread crop damage and reduce excessive pesticide use, thereby supporting sustainable agricultural practices. Artificial intelligence, particularly deep learning methods, has emerged as a transformative solution for automated plant disease diagnosis. Convolutional neural networks (CNNs) have demonstrated remarkable capabilities in image classification tasks, evolving from individual architectures to sophisticated ensembles and transferring learning models. However, existing CNN-based research on rice disease identification has typically focused on a limited number of disease classes, restricting their practical applicability in real-world agricultural settings. This study addresses these limitations by implementing DenseNet121, an advanced CNN architecture known for its efficient feature reuse and gradient flow, for comprehensive rice disease classification. We utilized a dataset comprising seven of the most common rice diseases, significantly expanding the scope beyond previous studies. The model employs transfer learning with pre-trained ImageNet weights and is optimized using the Adam optimizer with carefully tuned hyperparameters. The experimental evaluation on an independent test set demonstrates that our proposed model achieves an overall accuracy of 97.9%, with individual disease classification accuracy ranging from 94% to 99.67%. The model exhibits balanced performance across multiple metrics, including precision (96.2%), recall (97.97%), and F1-score (97%), confirming its robustness and generalizability. These results establish DenseNet121 as a highly effective framework for automated rice disease diagnosis, offering a practical tool for enhancing agricultural productivity and food security.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.